RNA-Analyseverfahren

European patent · EP2510114 · Deleted

Register entry

Publication number
EP2510114
Application number
EP10788340
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 10, 2010
Published
Oct 17, 2012
Granted
Apr 20, 2016
Deleted
Jul 23, 2026
Reason
Annual fee unpaid
IPC classes
C12Q 1/68 (2006.01)
Priority
EP 09178923 11.12.2009
PCT application
PCT/EP2010/069382 10.12.2010
PCT publication
WO2011/070155 16.06.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 23, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. Jan 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.12.2024 → 31.12.2025

    Published in Swissreg on 01.01.2025

  3. Jan 9, 2024

    Change

    Published in Swissreg on 09.01.2024

  4. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  5. Jun 29, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 29.06.2016

  6. Jun 29, 2016

    Address changed

    Owner
    Lexogen GmbH, Brunnerstrasse 69/Objekt 3, 1230 Vienna, Austria → Lexogen GmbH, Campus-Vienna-Biocenter 5, 1030 Wien, Austria

    Published in Swissreg on 29.06.2016

  7. Apr 20, 2016

    Granted

    Published in Swissreg on 20.04.2016

Parties

Inventor

SEITZ, Alexander

A-1140 Vienna, AT

PAUL, Lukas

A-1230 Vienna, AT

van MIN, Max Jan

NL-2497 ZJ Den Haag, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.